论文信息 - Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors. - 字舞流文

Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors.

M. Hidalgo | C. Erlichman | A. Adjei | J. Boni | E. Rowinsky | C. Zacharchuk | S. Quinn | P. Amorusi | Patricia Martins